BioSpace News Archive

US Bioservices, a specialty pharmacy that is a part of AmerisourceBergen, today announced that it has been selected by Verastem OncologyTM to dispense COPIKTRA™ (duvelisib) capsules.

incentaHEALTH has awarded six “Outstanding Partner in Health” awards to organizations positively impacting the health of their communities.

Advanced Analytics Software Platform Will Enhance Patient Safety, Speed Delivery of Care, and Support Quality Outcomes

PhenoPath deepens Quest’s presence in the Pacific Northwest while extending the company’s capabilities in anatomic pathology and molecular oncology

The Muscular Dystrophy Association (MDA) announced Adam Cotumaccio as executive vice president, chief impact and philanthropy officer, where he will lead the organization’s strategic direction for all income generating activities.

Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for orphan disorders, announced today that it has agreed to acquire Ichorion Therapeutics, Inc.

The global MRI-guided neurosurgical ablation market is projected to expand at a CAGR of 4.9% during the forecast period 2018–2028 and reach US$ 216.3 Mn by the end of 2028.

Hansa Medical AB (NASDAQ Stockholm: HMED), the leading biopharma company focusing on inhibition of immunoglobulin G (IgG)-mediated immunopathologies, announced today the successful completion of two Phase 2 clinical studies of imlifidase for kidney transplantation in highly sensitized patients, enabling transplantation in all 35 patients.

Stoke Therapeutics, Inc. will present research at the upcoming annual meeting of the Oligonucleotide Therapeutics Society supporting its approach of leveraging antisense oligonucleotides to increase protein expression for the treatment of Dravet Syndrome and other monogenic diseases.

Designation applies to development for the treatment of chronic anemia in patients with beta-thalassemia